Lovaza [Omega 3 ethylester concentrate] therapy of peripheral arterial disease.
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 14 May 2018
At a glance
- Drugs Omega-3-acid ethyl esters (Primary)
- Indications Hypertriglyceridaemia
- Focus Therapeutic Use
- 10 Mar 2010 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 12 Feb 2009 Planned end date changed from 1 Dec 2008 to 1 Dec 2010 as reported by ClinicalTrials.gov.
- 28 Dec 2007 New trial record.